Squarepoint’s Anika Therapeutics ANIK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-12,859
Closed -$212K 4527
2024
Q4
$212K Buy
+12,859
New +$254K ﹤0.01% 4429
2024
Q3
Sell
-21,648
Closed -$548K 4081
2024
Q2
$548K Sell
21,648
-30,809
-59% -$798K ﹤0.01% 3011
2024
Q1
$1.33M Sell
52,457
-6,098
-10% -$148K 0.01% 2367
2023
Q4
$1.33M Buy
58,555
+38,835
+197% +$804K 0.01% 2314
2023
Q3
$367K Buy
+19,720
New +$409K ﹤0.01% 3017
2022
Q2
Sell
-19,288
Closed -$484K 2857
2022
Q1
$484K Buy
+19,288
New +$588K ﹤0.01% 2027
2021
Q4
Sell
-4,921
Closed -$209K 3139
2021
Q3
$209K Sell
4,921
-7,015
-59% -$289K ﹤0.01% 2463
2021
Q2
$517K Buy
11,936
+6,074
+104% +$259K ﹤0.01% 2104
2021
Q1
$239K Buy
5,862
+489
+9% +$18.5K ﹤0.01% 2581
2020
Q4
$243K Buy
+5,373
New +$204K ﹤0.01% 2370
2020
Q1
Sell
-28,153
Closed -$1.46M 1836
2019
Q4
$1.46M Buy
28,153
+13,545
+93% +$787K 0.01% 1088
2019
Q3
$802K Buy
+14,608
New +$750K 0.01% 1375
2019
Q2
Sell
-9,800
Closed -$296K 2346
2019
Q1
$296K Sell
9,800
-11,763
-55% -$403K ﹤0.01% 1778
2018
Q4
$725K Buy
+21,563
New +$778K 0.01% 1057
2018
Q2
Sell
-10,536
Closed -$524K 1730
2018
Q1
$524K Buy
10,536
+4,026
+62% +$227K 0.01% 1075
2017
Q4
$351K Sell
6,510
-527
-7% -$29.2K 0.01% 1407
2017
Q3
$408K Buy
+7,037
New +$368K 0.01% 1051
2016
Q3
Sell
-3,955
Closed -$212K 998
2016
Q2
$212K Buy
+3,955
New +$186K 0.01% 872

Other funds holding ANIK